Member Exclusive INTERVIEW

#TalkingRegMed 7: Cell therapy and big pharma with Sven Kili, GSK

​In this exclusive video, Sven Kili, ‎VP and Head of Cell & Gene Therapy Development, GSK, explains why rare diseases are so amenable to treatment with cell therapies.

Thumb rme journal large
May 09, 2018
0
1

Please sign in or register for FREE

1 Comments

Thumb asymmetrex fb logo

Cell therapy production, tissue stem cell manufacturing in particular, is primarily limited by biology, not cost.

James Sherley at Asymmetrex